1. Home
  2. ECF vs VCEL Comparison

ECF vs VCEL Comparison

Compare ECF & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ECF
  • VCEL
  • Stock Information
  • Founded
  • ECF 1986
  • VCEL 1989
  • Country
  • ECF United States
  • VCEL United States
  • Employees
  • ECF N/A
  • VCEL N/A
  • Industry
  • ECF Finance/Investors Services
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ECF Finance
  • VCEL Health Care
  • Exchange
  • ECF Nasdaq
  • VCEL Nasdaq
  • Market Cap
  • ECF 138.8M
  • VCEL 2.1B
  • IPO Year
  • ECF N/A
  • VCEL 1997
  • Fundamental
  • Price
  • ECF $10.39
  • VCEL $38.02
  • Analyst Decision
  • ECF
  • VCEL Strong Buy
  • Analyst Count
  • ECF 0
  • VCEL 8
  • Target Price
  • ECF N/A
  • VCEL $62.00
  • AVG Volume (30 Days)
  • ECF 57.7K
  • VCEL 481.0K
  • Earning Date
  • ECF 01-01-0001
  • VCEL 07-31-2025
  • Dividend Yield
  • ECF 6.42%
  • VCEL N/A
  • EPS Growth
  • ECF N/A
  • VCEL 521.85
  • EPS
  • ECF 0.46
  • VCEL 0.05
  • Revenue
  • ECF N/A
  • VCEL $238,541,000.00
  • Revenue This Year
  • ECF N/A
  • VCEL $23.03
  • Revenue Next Year
  • ECF N/A
  • VCEL $24.52
  • P/E Ratio
  • ECF $17.61
  • VCEL $716.32
  • Revenue Growth
  • ECF N/A
  • VCEL 14.80
  • 52 Week Low
  • ECF $7.02
  • VCEL $36.97
  • 52 Week High
  • ECF $8.91
  • VCEL $63.00
  • Technical
  • Relative Strength Index (RSI)
  • ECF 71.21
  • VCEL 36.65
  • Support Level
  • ECF $10.36
  • VCEL $39.39
  • Resistance Level
  • ECF $10.47
  • VCEL $42.61
  • Average True Range (ATR)
  • ECF 0.09
  • VCEL 1.59
  • MACD
  • ECF 0.01
  • VCEL -0.29
  • Stochastic Oscillator
  • ECF 93.48
  • VCEL 0.00

About ECF Ellsworth Growth and Income Fund Ltd.

Ellsworth Growth and Income Fund Ltd operate as a closed-end, diversified management investment company. Its investment objective is to provide income and the potential for capital appreciation, which objectives the Fund considers to be relatively equal over the long term due to the nature of the securities in which it invests. The company invests in convertible and equity securities. It invests in various sectors, such as healthcare, financial services, computer software and services, energy and utilities, real estate investment trusts, semiconductors, telecommunications, business services, food and beverage, consumer products, transportation, consumer services among others.

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

Share on Social Networks: